Todays Zacks Rank Aggressive Growth Buy: Albany Molecular Research, Inc

has set a new 52-high coming off of a spectacular earnings announcement in August. The company has also initiated a Phase I study on a proprietary oncology drug and raised its full-year 2008 outlook. Company Description Albany Molecular Research, Inc. provides an extensive list of research and development services for pharmaceutical companies, such as drug development and chemistry research in addition to some... [read full story]